| Trial Identifier: | 215301 |
| Sponsor: | GlaxoSmithKline |
| Start Date: | October 2022 |
| Primary Completion Date: | November 2024 |
| Study Completion Date: | November 2024 |
| Condition: | Hepatitis B |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Belgium | Leuven, Belgium, 3000 |
| Germany | Koeln, Germany, 51069 |
| Germany | Magdeburg, Germany, 39120 |
| Germany, Hamburg | Hamburg, Germany, 22143 |
| United Kingdom | Cambridge, United Kingdom, CB2 2GG |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company